POS0929 FACTORS ASSOCIATED WITH THE DEVELOPMENT OF ANTI-DRUG ANTIBODIES TO TUMOUR NECROSIS FACTOR IN...
POS0929 FACTORS ASSOCIATED WITH THE DEVELOPMENT OF ANTI-DRUG ANTIBODIES TO TUMOUR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS; A TWO YEAR FOLLOW-UP STUDY
About this item
Full title
Author / Creator
Durak Ediboglu, E. , Solmaz, D. , Kabadayi, G. , Ozmen, M. , Çinar, M. , Sargin, G. , Karadag, O. , Kinikli, G. , Gerçik, Ö. , Kalyoncu, U. , Yilmaz, S. , Cefle, A. , Hatemi, G. , Senturk, T. , Keser, G. , Kicasik, B. , Yargucu, F. , Kozaci, L. and Akar, S.
Publisher
Elsevier B.V
Journal title
Language
English
Formats
Publication information
Publisher
Elsevier B.V
More information
Scope and Contents
Contents
Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic disease affecting sacroiliac joints and spine as well as peripheral joints and entheses. Tumour necrosis factor inhibitors (TNFi) are widely used in patients with persistently high disease activity despite non-steroidal anti-inflammatory drugs. Some patients fail to respond or loos...
Alternative Titles
Full title
POS0929 FACTORS ASSOCIATED WITH THE DEVELOPMENT OF ANTI-DRUG ANTIBODIES TO TUMOUR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS; A TWO YEAR FOLLOW-UP STUDY
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_primary_10_1136_annrheumdis_2021_eular_2215
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1136_annrheumdis_2021_eular_2215
Other Identifiers
ISSN
0003-4967
DOI
10.1136/annrheumdis-2021-eular.2215
